COVID-19 rapid guideline: managing the long-term effects of COVID-19

Published by National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) on Jan 14, 2022

Disclaimer

Sponsors

Contact

Abstract

Language

en-gb

PICOS

PICO 2.1

Population
Adults and children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Comparator
Outcomes

PICO 2.2

Population
Adults experiencing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes

PICO 2.3

Population
Adults experiencing symptoms beyond the duration of acute COVID-
Intervention
Not applicable
Comparator
Not applicable
Outcomes

PICO 2.4

Population
Children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes

PICO 2.5

Population
Children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes

PICO 5.1

Population
Adults and children experiencing ongoing symptoms beyond the duration of acute COVID-19 illness (>4 weeks)
Intervention
Not applicable
Comparator
Not applicable
Outcomes

PICO 6.1

Population
Adults and children who are experiencing new or ongoing symptoms: • 4-12 weeks from post-vaccination onset of acute COVID-19 illness • 12 weeks from post-vaccination onset of acute COVID-19 illness
Intervention
COVID-19 Vaccination
Comparator
No vaccination
Outcomes

PICO 6.2

Population
Adults and children who are experiencing new or ongoing symptoms: • 4-12 weeks from pre-vaccination onset of acute COVID-19 illness • 12 weeks from pre-vaccination onset of acute COVID-19 illness
Intervention
COVID-19 Vaccination
Comparator
No vaccination
Outcomes